Literature DB >> 10591987

Early onset of lithium prophylaxis as a predictor of good long-term outcome.

L Franchini1, R Zanardi, E Smeraldi, M Gasperini.   

Abstract

The recurrence rates during lithium preventive treatment were investigated in a sample of 270 Mood Disorder subjects subdivided according to their onset time for lithium prophylaxis as very early (within 5 years from the onset of illness), early (6-10 years), late (11-20 years) and very late (more than 21 years). 131 subjects of the sample followed for 4 years prolonged the observation for a further period of 8 years. Results indicated that beginning lithium therapy within the first ten years of illness predicts better preventive outcomes than beginning prophylaxis later, both in major depression, recurrent and bipolar patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10591987     DOI: 10.1007/s004060050091

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  24 in total

Review 1.  Staging bipolar disorder.

Authors:  Eduard Vieta; M Reinares; A R Rosa
Journal:  Neurotox Res       Date:  2010-05-12       Impact factor: 3.911

Review 2.  Stage managing bipolar disorder.

Authors:  Michael Berk; Lesley Berk; Seetal Dodd; Sue Cotton; Craig Macneil; Rothanthi Daglas; Philippe Conus; Andreas Bechdolf; Steven Moylan; Gin S Malhi
Journal:  Bipolar Disord       Date:  2013-06-20       Impact factor: 6.744

3.  Age at onset, course of illness and response to psychotherapy in bipolar disorder: results from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

Authors:  A Peters; L G Sylvia; P V da Silva Magalhães; D J Miklowitz; E Frank; M W Otto; N S Hansen; D D Dougherty; M Berk; A A Nierenberg; T Deckersbach
Journal:  Psychol Med       Date:  2014-04-10       Impact factor: 7.723

4.  Staging in bipolar disorder: from theoretical framework to clinical utility.

Authors:  Michael Berk; Robert Post; Aswin Ratheesh; Emma Gliddon; Ajeet Singh; Eduard Vieta; Andre F Carvalho; Melanie M Ashton; Lesley Berk; Susan M Cotton; Patrick D McGorry; Brisa S Fernandes; Lakshmi N Yatham; Seetal Dodd
Journal:  World Psychiatry       Date:  2017-10       Impact factor: 49.548

Review 5.  Mechanisms of illness progression in the recurrent affective disorders.

Authors:  Robert M Post
Journal:  Neurotox Res       Date:  2010-11       Impact factor: 3.911

Review 6.  A comprehensive review and model of putative prodromal features of bipolar affective disorder.

Authors:  O D Howes; S Lim; G Theologos; A R Yung; G M Goodwin; P McGuire
Journal:  Psychol Med       Date:  2010-09-14       Impact factor: 7.723

Review 7.  Kidney, thyroid and other organ functions after 40 years or more of lithium therapy: a case series of five patients.

Authors:  Agnieszka Permoda-Osip; Maria Abramowicz; Agnieszka Kraszewska; Aleksandra Suwalska; Maria Chlopocka-Wozniak; Janusz K Rybakowski
Journal:  Ther Adv Psychopharmacol       Date:  2016-04-17

8.  Effectiveness and outcome predictors of long-term lithium prophylaxis in unipolar major depressive disorder.

Authors:  Christopher Baethge; Philipp Gruschka; Michael N Smolka; Anne Berghöfer; Tom Bschor; Bruno Müller-Oerlinghausen; Michael Bauer
Journal:  J Psychiatry Neurosci       Date:  2003-09       Impact factor: 6.186

9.  Hypomanic symptoms in female undergraduate students diagnosed with unipolar depression based on scores on the hypomania checklist.

Authors:  Thomas Richardson; Hugh Garavan
Journal:  Clin Pract Epidemiol Ment Health       Date:  2009-12-18

10.  A cluster analytic approach to identifying predictors and moderators of psychosocial treatment for bipolar depression: Results from STEP-BD.

Authors:  Thilo Deckersbach; Amy T Peters; Louisa G Sylvia; Alexandra K Gold; Pedro Vieira da Silva Magalhaes; David B Henry; Ellen Frank; Michael W Otto; Michael Berk; Darin D Dougherty; Andrew A Nierenberg; David J Miklowitz
Journal:  J Affect Disord       Date:  2016-05-31       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.